Keyword: Fluarix Quadrivalent
Seqirus expects to offer 50 million flu vaccine doses, while GSK plans to boost its supplies to 40 million to 45 million, its highest total ever.
GlaxoSmithKline is touting phase 3 study data showing its Fluarix Tetra can protect young children who are among the most vulnerable to the virus.
Health experts presented flu vaccination guidelines stressing there's no difference in safety for shots given people allergic to eggs.
GSK's meningitis vaccine fueled vaccines growth that far outpaced the company's pharma unit, and a new plant and forthcoming launch could keep the momentum going.
Just a month after winning a big government contract for pandemic flu preparedness, Protein Sciences has notched an FDA approval for its next flu vaccine offering.
This past season's flu vaccines posted one of the worst efficacy rates in recent memory. That's partly because the viral strains they contained weren't the ones that ended up circulating. But on top of that, GlaxoSmithKline has uncovered some other effectiveness problems of its own--and now it's recalling a quadrivalent jab in a move that affects 1.7 million doses.